mFast-SeqS as a Monitoring and Pre-screening Tool for Tumor-Specific Aneuploidy in Plasma DNA-Reference-Cited by-同舟云学术

mFast-SeqS as a Monitoring and Pre-screening Tool for Tumor-Specific Aneuploidy in Plasma DNA

Published:2016 Issue: Volume: Page:147-155
ISSN:0065-2598
Container-title:Advances in Experimental Medicine and Biology
language:
Short-container-title:

Author:

Belic Jelena,Koch Marina,Ulz Peter,Auer Martina,Gerhalter Teresa,Mohan Sumitra,Fischereder Katja,Petru Edgar,Bauernhofer Thomas,Geigl Jochen B.,Speicher Michael R.,Heitzer Ellen

Publisher

Springer International Publishing

Link

http://link.springer.com/content/pdf/10.1007/978-3-319-42044-8_28

Reference18 articles.

1. Belic J, Koch M, Ulz P et al (2015) Rapid identification of plasma DNA samples with increased ctDNA levels by a modified FAST-SeqS approach. Clin Chem 61:838–849

2. Bettegowda C, Sausen M, Leary RJ et al (2014) Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med 6:224ra24

3. Chan KC, Jiang P, Chan CW et al (2013a) Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing. Proc Natl Acad Sci U S A 110:18761–18768

4. Chan KC, Jiang P, Zheng YW et al (2013b) Cancer genome scanning in plasma: detection of tumor-associated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencing. Clin Chem 59:211–224

5. Diaz LA Jr, Bardelli A (2014) Liquid biopsies: genotyping circulating tumor DNA. J Clin Oncol 32:579–586

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetic and Genomic Hallmarks of PARP-Inhibitor Resistance in Ovarian Cancer Patients;Genes;2024-06-07

2. Accurate detection of copy number aberrations in FFPE samples using the mFAST-SeqS approach;Experimental and Molecular Pathology;2024-06

3. Non-invasive multi-cancer diagnosis using DNA hypomethylation of LINE-1 retrotransposons;2024-01-23

4. Critical Factors in the Analytical Work Flow of Circulating Tumor DNA-Based Molecular Profiling;Clinical Chemistry;2024-01

5. The changing face of circulating tumor DNA (ctDNA) profiling: Factors that shape the landscape of methodologies, technologies, and commercialization;Medizinische Genetik;2023-11-29